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A strict control of endolymph composition (high potassium, low sodium ﬂuid) and volume is instru-
mental for a proper functioning of the inner ear. Alteration of endolymph homeostasis is proposed
in the pathogenesis of Menière’s disease. However, the mechanisms controlling endolymph secre-
tion remain elusive. By using the vestibular EC5v cells, we provide evidence for the presence of vaso-
pressin, catecholamine and purinergic signaling pathways, coupled to adenylate cyclase,
phosphoinositidase C and Ca2+ activation. We demonstrate that vasopressin and catecholamines
stimulate while ATP inhibits apical potassium secretion by EC5v cells. These results open new inter-
esting perspectives for the management of inner ear diseases.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The inner ear houses the hearing (cochlea) and balance (saccule,
utricule, semicircular canals) organs. Endolymph, the ﬂuid thatchemical Societies. Published by E
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28 Biosciences Gerland, Lyonbathes the apical hair bundles of the sensory cells, is unique with
a high K+ concentration (170 mM), and virtually no Na+ (1 mM).
Furthermore, the transepithelial potential (endocochlear potential)
is +100 mV, lumen positive. Homeostasis of the volume, pressure,
and electrochemical composition of endolymph is pivotal for an
accurate functioning of the sensory cells. Indeed, it has been pro-
posed that vertigo and hearing loss, such as in Menière’s disease,
a syndrome linked to an increase of endolymph volume (hydrops),
may result from dysfunctions in inner ear epithelial ionic trans-
port, notably K+. For example, the most frequent etiology of con-
genital deafness, due to connexin 26 mutations, is related to K+
recycling dysfunction [1]. Jervell and Lange–Nielsen syndrome, a
long QT syndrome, associated to hearing loss, is caused by muta-
tions in KCNE1 and KCNQ1 genes, encoding the K+ channel involved
in endolymphatic K+ secretion [2]. Thus, investigations on the
molecular mechanisms controlling ionic composition of endo-
lymph, and on water transport through the labyrinthine epithe-
lium are critical to open new therapeutic options in the
management of inner ear defects.
The development of a new vestibular cell line (EC5v) [3] that
expresses all transporters known to be involved in endolymphlsevier B.V. All rights reserved.
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trolling ionic transport via the two main regulatory pathways,
phosphoinositidase C (PLC)/Ca2+ and adenylate cyclase pathways.
Indeed, evidence has been provided for a regulating role of extra-
cellular Adenosine Triphosphate (ATP) and Uridine Triphosphate
(UTP), which act through a PLC stimulation, on both neurotrans-
mission and endolymph homeostasis [4]. Furthermore, the puta-
tive effects of polypeptidic hormones, coupled to adenylate
cyclase activation, have been largely studied in the inner ear, spe-
ciﬁcally antidiuretic hormone Arginine Vasopressin (AVP) that has
been proposed to be involved in Menière’s disease [2,5].
The present study aimed at investigating, in EC5v, the hormonal
regulatory pathways mediated by transmembrane G Protein-Cou-
pled Receptors (GPCR) via the stimulation of PLC or adenylate cy-
clase. For comparison, similar experiments were performed in
renal KC3AC1 cells, derived from the cortical collecting duct
(CCD). Indeed, several ionic transporters are expressed in both
the inner ear and kidney, and their defects result in simultaneous
dysfunctions of these seemingly unrelated organs [6]. This study
provides direct evidence that AVP and ATP regulate K+ secretion
on inner ear epithelium, and may be involved in the regulation
of endolymph ionic composition and volume.
2. Materials and methods
2.1. Cell culture
The inner ear EC5v (from the ampulla of semicircular canals)
and the renal KC3AC1 cells (from microdissected CCD) were estab-
lished by a targeted oncogenesis strategy in mice, and were further
characterized [3,7]. Both cell lines from passage 10 to 40 were cul-
tured at 37 C in an humidiﬁed incubator with 5% CO2 on collagen
I-coated Petri dishes, or, when indicated, on Transwell ﬁlters with
an epithelial culture medium (Supplementary Table 1).
2.2. Products
Radioactive products were purchased from GE Life Sciences (Les
Ulis, France), drugs and chemicals were from Sigma (Saint-Louis,
MO, USA), except when indicated.
2.3. RT-PCR
Total RNA was extracted from cells with TRIZOL reagent (Invit-
rogen) according to the manufacturer’s recommendations and RNA
was thereafter processed for RT-PCR, as previously described [3].
Supplementary Table 2 indicates primer sequences.
2.4. Western blot
Total protein extracts were prepared as previously described
[7]. Immunoblots were incubated overnight at 4 C with anti-vaso-
pressin type 2 receptor (V2R) and anti-a-tubulin antibodies (see
Supplementary Table 3). After 1 h incubation at room temperature
with ﬂuorescent secondary antibodies, membranes were scanned
using the Odyssey infrared imaging system and images were pro-
cessed with the Image Studio Software (LI-COR Biosciences).
2.5. cAMP assay
As previously described [8], conﬂuent cells were scrapped and
incubated for 5 min with the various compounds. cyclic Adenosine
Monophosphate (cAMP) contents (fmol/5 min/lg protein) were
measured by radioimmunoassay (Biotrack™ assay system, GE Life
Sciences).2.6. Phosphoinositidase C assay
Enzymatic studies were performed as described earlier [9].
Brieﬂy, conﬂuent cells were loaded overnight with 0.5 MBq myo-
[3H] inositol (2.6 TBq/mmol). A 30 min incubation at 37 C was
started by adding cells (20 lg protein) in PLC incubation medium
(Supplementary Table 1) in presence of LiCl to inhibit the inositol
phosphates hydrolysis and various compounds. Radioactivity asso-
ciated to free inositol, glycerophosphoinositol (GroPns), total inosi-
tol phosphates (RInsPs), and incorporated in total (R)
phosphoinositides were determined. Results (mean ± SE) were ex-
pressed as radioactive ratios between speciﬁc inositol-containing
pool and total labeled inositol-containing cellular pools (the latter
were 2215 ± 694 cpm, n = 10, and 8330 ± 1727 cpm, n = 11) for
KC3AC1 and EC5v cells, respectively.
2.7. Ca2+ assay
Cytosolic free calcium concentration [Ca2+]i was measured on
cellular suspensions as previously described [10]. Cells were
loaded with Fura-2 for 45 min at 37 C. Fluorescence was moni-
tored in a F2000 spectroﬂuorometer (Hitachi Scientiﬁc Instru-
ments, Mountain View, CA, USA). [Ca2+]i was calculated using a
dissociation constant (KD) of 224 nM.
2.7.1. 86Rb transport
As previously described [3], 106 cells seeded on Transwell ﬁl-
ters, were cultured for 5 d in the epithelial culture medium. 86Rb
(185 kBq/well) was added in the basolateral compartment. 86Rb
ﬂux was evaluated by sampling 5 ll of apical ﬂuid at 15 min inter-
val. Fluxes (nmol/cm2) were calculated as a function of K+ concen-
tration and the speciﬁc radioactivity (18.5–37.0 MBq/mg Rb),
assuming that 86Rb is a strict marker of K+. Results are means of
at least 6 independent ﬁlters.
2.8. Calculations
The kinetics agonist-induced cyclic AMP productions and/or PLC
activation are calculated as previously described [11]. Results were
given as means ± SE of n independent replicates performed in the
same experiment or from n separated experiments. Differences be-
tween groups were analyzed using ANOVA followed by Dunnett’s
multiple comparison test or Student’s t test when indicated. The
signiﬁcance was achieved for a P < 0.05.
3. Results
3.1. Expression of AVP and P2Y receptors
RT-PCR analyses revealed the presence of transcripts coding for
GPCR V1a, V2, Oxt, P2Y2, and P2Y4 receptors in EC5v while KC3AC1
expressed transcripts for V2, P2Y2 and P2Y6 receptors. Speciﬁc
amplicons were identiﬁed at the expected sizes and their se-
quences conﬁrmed (Supplementary Fig. 1). Western blot analysis
conﬁrmed the presence of V2R protein at the expected molecular
mass (60 KDa) in both cell lines (Supplementary Fig. 2).
3.2. Pharmacological characterization of adenylate cyclase stimulation
In EC5v, cAMP production was 218 ± 44, and 1281 ± 202 fmol
cAMP/5 min/lg protein (n = 7), in basal and forskolin (FSK)-stimu-
lated conditions, respectively. The corresponding values were
608 ± 116 and 13 758 ± 6360 fmol cAMP/5 min/lg protein (n = 6)
for KC3AC1, consistent with the presence of a functional adenylate
cyclase system in both epithelial cell lines.
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no-8D-arginine-vasopressin (dDAVP), calcitonin, parathormone
(PTH), or prostaglandin E2 (PGE2) exposure, but was drastically in-
creased by FSK and isoproterenol, this latter effect being inhibited
by propranolol (Fig. 1A). The isoproterenol-induced activation of
cAMP production was dose-dependent (Fig. 1B) with a threshold
response for about 10 nM, an apparent activation constant
Ka = 70 nM, a Hill coefﬁcient nH = 1.9, and a maximal response ob-
served for about 0.4 lM (maximal stimulating factor SF: 4.9).
In KC3AC1, basal cAMP production remained unchanged upon
PTH and calcitonin administration, but was slightly increased by
isoproterenol and PGE2, and markedly enhanced by dDAVP and
FSK (Fig. 1C). The isoproterenol-induced cAMP production was
inhibited by propranolol, and the enzyme stimulation elicited by
dDAVP was reduced in the presence of antagonists Ornithine Vaso-
tocin Analogue (OVTA) or desGly9,Tyr(Et)2VAVP (desGly). The
dDAVP-induced activation was dose-dependent (Fig. 1D) with the
following kinetic parameters: threshold response for 5 nM,
Ka = 2.8 nM, nH = 1.7, and SF = 18. Maximal responses to saturating
amounts of dDAVP, isoproterenol and PGE2 were not additive (Sup-
plementary Fig. 3).
Comparing these two cell lines, it is worth noting that, whereas
V2 receptors are expressed in both cell lines, dDAVP did not induce
an adenylate cyclase stimulation in EC5v at variance to what is ob-
served in KC3AC1.EC5v
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Fig. 1. Hormonal sensitivity of adenylate cyclase in EC5v (A, B) and KC3AC1 (C, D) cells. R
measured under basal conditions or in presence of either 1 lM dDAVP, 5 lM calcitonin
(Propra), 0.5 lM PGE2, or 5 lM FSK. ⁄⁄⁄: differences between basal and drug induced cA
isoproterenol (P < 0.0001, Student). (B) Dose-dependent stimulation of cAMP product
coefﬁcient nH = 1.9. (C) cAMP production were measured under basal conditions or in pre
hPTH, 0.1 lM Iso, ±10 lM Propra, 0.5 lM PGE2, or 5 lM FSK. Differences between basal a
desGly decreased response to dDAVP (P < 0.01 and 0.001, respectively, Student); £: propr
dependent stimulation of cAMP production by dDAVP. Apparent activation constant Ka3.3. Pharmacological characterization of PLC stimulation
The basal production of total [3H]InsPs was not modiﬁed by
pharmacological concentrations of either angiotensin II, bradyki-
nine, phenylephrine, AVP, the V1a agonist [Phe2,Orn8]VT, or carba-
chol (Supplementary Table 4). In contrast, Inositol Phosphates
(InsPs) production was markedly and similarly enhanced by
1 mM ATP (4.65 ± 0.24 and 7.35 ± 0.17% of the total incorporated
[3H]InsP production in EC5v and KC3AC1, respectively) or UTP
(4.69 ± 0.17 and 7.17 ± 0.22% in EC5v and KC3AC1, respectively).
In both cell lines, ATP increased PLC activities in a dose-depen-
dent fashion according to Michaelian kinetics with the following
kinetic parameters: Threshold response for 0.10 lM, pKa values
6.1 and 6.2, Hill coefﬁcient nH = 0.82 and 0.98, and maximal stim-
ulating factors 3.4 and 4.0, for EC5v and KC3AC1 cells, respectively
(Fig. 2A and B).
The sensitivity of PLC to structural ATP analogues shares some
similarities between EC5v and KC3AC1: Their apparent activation
constant (Ka) for ATP, adenosine 50-0-(3-thriophosphate) (ATPcS),
and UTP were lower than those of the other tested analogues,
and, considering their intrinsic activities (Max/ATPmax), ADP-b-S
exhibited weak agonistic potencies whereas Uridine Diphosphate
(UDP), Uridine Monophosphate (UMP), AMP, adenosine, uridine
and cAMP were almost devoid of activities (Supplementary
Table 5).EC5v
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esults are mean ± SE of ﬁve independent determinations. (A) cAMP production were
, 5 lM human parathormone (hPTH), 0.1 lM isoproterenol (Iso), ±10 lM propranol
MP production (P < 0.001, ANOVA); $: propranolol decreased the cAMP response to
ion by isoproterenol. Apparent activation constant Ka = 70 nM (arrow), and Hill
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nd drug-induced cAMP production: ⁄⁄⁄: P < 0.001, ⁄: P < 0.05 (ANOVA); $: OVTA and
anolol decreased the cAMP response to isoproterenol (P < 0.005, Student). (D) Dose-
= 2.8 nM (arrow), and Hill coefﬁcient nH = 1.7.
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Fig. 2. ATP-sensitive phosphoinositidase C (A, B), and Ca2+-dependent pathway (C, D), in EC5v (A, C) and KC3AC1 (B, D) cells. (A, B) Results are means ± SE of ﬁve independent
determinations (See Supplementary Table 4). (C, D) Intracellular free Ca2+ mobilization were monitored with Fura-2 on cell suspension after the addition (arrows) of either
10 lM Phe2, Orn8- vasotocin: [Phe2, Orn8]VT (poVT), 10 lM AVP, or 1 mM ATP.
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between cell lines resulted mainly in the potencies of the potent
marker of P2X7 receptors 20- and 30-0-4-(benzoyl benzyl)-ATP
(Bz-ATP) that stimulated PLC of KC3AC1 with an apparent afﬁnity
one order of magnitude higher than that for the EC5v, and the po-
tent agonist of P2Y4 receptors b,c-methylene ATP (b,c-Me-ATP)
that stimulate enzyme in EC5v with a Ka value 10 times lower than
that of KC3AC1 (Supplementary Table 5). The results observed in
the two cell lines suggest different coupling procedures probably
due to distinct functional properties of the cells.
Considering the PLC pathway, no major difference on stimulat-
ing hormone pattern was observed between the two cell lines, ex-
cept subtle variations in PLC sensitivity to structural ATP
analogues.
3.4. Intracellular Ca 2+ response to AVP and ATP
Owing to results of RT-PCR and PLC studies, we further investi-
gate [Ca2+]i variations. In both cell lines, no Ca2+ response occurred
inpresenceofAVP, or thepotentV1aagonist [Phe2,Orn8]VTwhereas
ATP exposure induced a rapid increase in [Ca2+]i followed by a sus-
tained plateau (Fig. 2C and D), suggesting an efﬁcient coupling be-
tween ATP receptors, PLC activation, and cellular Ca2+ release.
3.5. K+ transport
In EC5v, K+ secretion, from basolateral to apical compartments,
was clearly increased by 2-fold upon dDAVP or isoproterenol stim-
ulation, and by 3-fold upon FSK stimulation, and was slightly, but
signiﬁcantly, inhibited by ATP (Fig. 3A).
In KC3AC1, K+ secretion was increased by 3-fold upon dDAVP
and by 2-fold upon FSK, but was inhibited by isoproterenol(Fig. 3B). At variance with that observed for EC5v, K+ transport
was decreased by 50% by isoproterenol.
These results demonstrate that dDAVP, isoproterenol, and ATP,
clearly differentially regulate K+ transport, in both EC5v and
KC3AC1.
4. Discussion
Epithelial cells receive hormonal inputs that regulate volume
and electrolyte homeostasis. This regulation is of major importance
in the kidney to control ionic transports and plasma composition.
This ﬁne tuning control is also crucial in the inner ear to strictly
maintain the endolymph composition and volume, thereby pre-
venting any hearing and balance dysfunction. In the present study,
we provide ﬁrst evidence that three different signaling cascades
are functional in the inner ear. Indeed, we demonstrate that the
b-adrenergic catecholamines (isoproterenol), the antidiuretic hor-
mone (AVP), and the nucleotides (ATP and its agonists) activate
their effectors, adenylate cyclase or PLC in vestibular EC5v cells.
We also show that apical K+ secretion in EC5v is markedly yet dif-
ferentially affected by these stimuli.
4.1. Catecholamine regulation
In the inner ear, b-adrenergic receptors are present in the endo-
lymph secretory structures, stria vascularis in the cochlea and dark
cells in the vestibule [12]. The stimulating effect of isoproterenol
on adenylate cyclase/cAMP system has been extensively studied
[13,14]. Furthermore, isoproterenol has been shown to stimulate
the short circuit current in isolated dark cell epithelium, suggesting
a stimulating effect on endolymph secretion [13]. Our results dem-
onstrate the presence of this regulatory system and the stimulation
KC3AC1
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Fig. 3. Calculated basolateral to apical transepithelial K+ ﬂux with 86Rb determi-
nation in basal condition, and in presence of FSK (5 lM), dDAVP (0.1 lM), Iso
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ATP in EC5v.
J. Nevoux et al. / FEBS Letters 585 (2011) 2703–2708 2707of K+ secretion in EC5v, suggesting the implication of catechol-
amine signaling pathway in balance and, possibly in hearing.
Catecholamines could induce acute disturbance of endolymph
homeostasis, and may be involved in Menière’s disease crisis, often
trigged by acute stress.
In the late nephron, the main regulatory site for K+ excretion,
b-adrenergic agonists inhibits K+ secretion [15], an effect that
was clearly observed in KC3AC1.
Even though, b-adrenergic agonists stimulate cAMP production
in both EC5v and KC3AC1 cells, the functional consequences of
activated adrenergic cascade on apical K+ secretion clearly differ
between the inner ear and renal cells. Nevertheless, b-adrenergic
agonists act in order to maintain low or high K+ concentration in
plasma or endolymph, respectively.
4.2. Antidiuretic hormone regulation
The putative effect of AVP in the inner ear has been extensively
studied [16], mainly because of possible therapeutic applications
in Menière’s disease. However, the presence of V2R and AVP effect
on endolymph homeostasis still remain debatable. In vestibular
EC5v, AVP receptors have been clearly identiﬁed at both mRNA
and protein levels, and AVP exposure led to a marked increase in
apical K+ secretion. Nevertheless, V2R activation was not efﬁciently
coupled to cAMP production. The underlying coupling mechanisms
remain to be elucidated, but could be related to the receptor number
and their localization in microdomains of the plasmamembrane or,
more likely, to GPRC linked effectors, speciﬁcally expressed in these
inner ear cells.
In sharp contrast, the presence of functional V2 receptors has
been unambiguously demonstrated in CCD [17,18]. AVP increasedthe number and the activity of basolateral Na+,K+-ATPase [19], pro-
moting Na+ absorption and K+ secretion [20]. In KC3AC1, we clearly
showed that AVP, presumably via V2R activation, dose-depen-
dently stimulated cAMP production and increased apical K+
secretion.
Collectively, the exact cellular mechanisms by which AVP stim-
ulates K+ conductance and controls K+ homeostasis remain elusive
but clearly differ between renal excretion and endolymphatic
secretion of K+.
4.3. Purinergic regulation
Purines, particularly ATP, act as neurotransmitters and para-
crine factors in different organs. Endolymph homeostasis is regu-
lated by ATP, released during noise exposure or hypoxia, acting
on both ionotropic (P2X) and metabotropic (P2Y) receptors [21].
ATP inhibits the KCNE1/KCNQ1 channel involved in endolymph
K+ secretion, through activation of P2Y4 receptor/PLC/Protein
Kinase C pathway [22]. In EC5v, P2Y4 have been identiﬁed, and
ATP was shown to stimulate PLC pathway and to slightly decrease
K+ secretion as previously shown in native tissue [23].
Although P2Y2 receptors have been identiﬁed in CCD [24],
inhibiting ENaC-dependant Na+ transport [25], their impact on K+
secretion remains questionable.
This study demonstrates the presence of regulatory mecha-
nisms in endolymph secretory cells, supporting a precise regula-
tion of high K+ concentration in endolymph that slightly differs
from renal K+ excretion. Given that modiﬁcation of endolymph
composition induces hearing and/or balance disturbances, a better
characterization of the signaling pathways involved in endolymph
homeostasis is pivotal to develop innovative therapeutic
approaches controlling K+ secretion and water movements.Acknowledgments
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